Alps Advisors Inc Acadia Pharmaceuticals Inc Transaction History

Alps Advisors Inc

$17.2 Billion
Q2 2025

A detailed history of Alps Advisors Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 111,895 shares of ACAD stock, worth $2.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

111,895

Previous 140,225 20.2%

Holding current value

$2.34 Million

Previous $2.33 Million 3.61%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$14.1 - $22.95 $399,453 - $650,173	-28,330 Reduced 20.2%	111,895 $2.41 Million
Q1 2025 Apr 30, 2025	BUY	$16.61 - $20.29 $94,361 - $115,267	5,681 Added 4.22%	140,225 $2.33 Million
Q4 2024 Feb 13, 2025	BUY	$14.29 - $18.76 $106,431 - $139,724	7,448 Added 5.86%	134,544 $2.47 Million
Q3 2024 Nov 12, 2024	SELL	$15.14 - $19.14 $26,797 - $33,877	-1,770 Reduced 1.37%	127,096 $1.96 Million
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $184,855 - $232,902	12,644 Added 10.88%	128,866 $2.09 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $79,859 - $138,530	4,489 Added 4.02%	116,222 $2.15 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $188,620 - $288,376	-9,077 Reduced 7.51%	111,733 $3.5 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $26,550 - $42,640	1,274 Added 1.07%	120,810 $2.52 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $225,223 - $324,549	12,653 Added 11.84%	119,536 $2.86 Million
Q1 2023 May 10, 2023	SELL	$16.32 - $20.92 $46,038 - $59,015	-2,821 Reduced 2.57%	106,883 $2.01 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $302,999 - $397,526	21,338 Added 24.15%	109,704 $1.75 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $86,324 - $111,775	-6,118 Reduced 6.48%	88,366 $1.45 Million
Q2 2022 Aug 11, 2022	SELL	$13.01 - $27.22 $926,272 - $1.94 Million	-71,197 Reduced 42.97%	94,484 $1.33 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $426,401 - $559,982	-20,363 Reduced 10.95%	165,681 $4.01 Million
Q4 2021 Feb 09, 2022	SELL	$16.79 - $27.09 $182,171 - $293,926	-10,850 Reduced 5.51%	186,044 $4.34 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $209,637 - $329,069	-13,285 Reduced 6.32%	196,894 $3.27 Million
Q2 2021 Aug 11, 2021	BUY	$19.4 - $27.42 $4.08 Million - $5.76 Million	210,179 New	210,179 $5.13 Million
Q4 2019 Feb 07, 2020	SELL	$36.21 - $51.4 $7.65 Million - $10.9 Million	-211,163 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$22.22 - $44.01 $1.99 Million - $3.94 Million	-89,587 Reduced 29.79%	211,163 $7.6 Million
Q2 2019 Aug 07, 2019	BUY	$23.32 - $28.12 $7.01 Million - $8.46 Million	300,750 New	300,750 $8.04 Million
Q4 2017 Feb 05, 2018	SELL	$26.84 - $39.14 $3.24 Million - $4.72 Million	-120,544 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$29.49 - $38.37 $3.55 Million - $4.63 Million	120,544	120,544 $4.54 Million

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

164M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Acadia Pharmaceuticals Inc Transaction History